Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadazolid Phase 2 in CDAD
NCT01222702Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jan 2011
- Primary completion
- Oct 2012
- Modality
- Bivalent/Multivalent Binders, Orthosteric Ligands, RNA-Targeting Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of cadazolid in Clostridioides difficile infection (CDI), sponsored by Actelion Pharmaceuticals Ltd. Started Jan 2011; status: completed.
02
Drugs
cadazolid
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT01222702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222702.